Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05015803 · ClinicalTrials.gov registry record · Phase 2
Enhanced CBTi for Older Adult Sleep and Cognition
A Phase 2 study, sponsored by Penn State University.
- Completed
- Registry status
- Phase 2
- Development phase
- 60
- Enrollment target
NCT05015803: Completed Phase 2 study, sponsored by Penn State University.
NCT05015803 is a Phase 2 study that has completed, run by Penn State University. The registered enrollment target is 60 participants, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (55% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05015803, a Phase 2 study, has completed, sponsored by Penn State University.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 60 participants
- Enrollment target
Study Summary
This randomized clinical trial on 60+ aged and independent-living healthy individuals with symptoms of insomnia will attempt to improve sleep and health outcomes related to sleep with enhancement of a clinical intervention, Cognitive Behavioral Therapy for Insomnia (CBTi).
Primary Outcome
Subjective patient completion of the Insomnia Severity Index survey. Sum of survey item responses; Minimum score: 0; Maximum score: 28. Higher sum score indicates a greater number of, or more severe, insomnia symptoms; reduction in sum score suggests improvement of insomnia.
Interventions
- BEHAVIORAL Sleep Hygiene Education
- COMBINATION_PRODUCT CBTi with Application
- BEHAVIORAL CBTi
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2022-03-16 |
| Est. Completion | 2023-08-16 |
| Phase | Phase 2 |
What the finished NCT05015803 record still lists
NCT05015803 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 60 participants, a relatively small participant target, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (55% lower).
The record links to 0 conditions, and to 3 interventions - of which Sleep Hygiene Education is the first listed.
NCT05015803 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05015803 about?
NCT05015803 is a clinical study titled "Enhanced CBTi for Older Adult Sleep and Cognition". This randomized clinical trial on 60+ aged and independent-living healthy individuals with symptoms of insomnia will attempt to improve sleep and health outcomes related to sleep with enhancement of a clinical intervention, Cognitive Behavioral Therapy for Insomnia (CBTi).
What is the current status of trial NCT05015803?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 60 participants. The study started on 2022-03-16. Estimated completion is 2023-08-16.
What interventions are being tested in trial NCT05015803?
The interventions under investigation include: Sleep Hygiene Education (BEHAVIORAL), CBTi with Application (COMBINATION_PRODUCT), CBTi (BEHAVIORAL).
Who is sponsoring clinical trial NCT05015803?
This trial is sponsored by Penn State University, which has 219 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05015803's enrollment target sits among peer trials
60 1027th of 2000 higher than 868 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00576069 · 60 participants
Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma
- NCT01297400 · 60 participants · Phase 2
Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns
- NCT01734122 · 60 participants
Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor
- NCT01804634 · 60 participants · Phase 2
Reduced Intensity Haploidentical BMT for High Risk Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI